Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren's disease
- PMID: 40393919
- DOI: 10.1016/j.ard.2025.04.020
Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren's disease
Abstract
Objectives: Salivary gland epithelial cells (SGECs) play a key role in Sjögren's disease (SjD) as an active contributor to the pathogenesis. Current models lack clear epithelial readouts. Our aim was to establish a more advanced model by developing salivary gland organoids (SGOs) from labial salivary gland biopsies (LSGBs) of SjD patients and sicca controls.
Methods: We included SjD patients fulfilling the American College of Rheumatology/European League Against Rheumatism 2016 criteria and sicca controls. LSGBs were dissociated, encapsulated in extracellular matrix, and submerged in growth expansion medium for long-term culture. SGOs were primarily cultured in differentiation medium and then transferred to a low attachment plate to form differentiated SGOs (DIF-SGOs).
Results: We included 13 SjD and 15 controls. In both groups, SGOs were formed, demonstrating long-term culture viability and comparable self-renewal capacity (3.3 ± 1.7 months). DIF-SGOs comparably exhibited mature acinar (aquaporin 5, amylase), ductal (cytokeratins 5 and 7) and myoepithelial (α-smooth muscle actin) markers in both groups. DIF-SGOs were responsive to inflammation by expressing BAFF, CXCL10 and IL7 upon stimulation with poly(I:C) and interferon-α. DIF-SGOs also demonstrated a swelling response to cholinergic stimulation by pilocarpine. We observed significant differences between SjD- and control-derived SGOs. Notably, SjD-derived DIF-SGOs consistently maintained a persistent interferon signature throughout long-term culture. In addition, the swelling capacity was reduced in SjD-derived DIF-SGOs compared to control. However, treatment with tofacitinib enhanced the swelling ability, suggesting a potential effect on saliva production.
Conclusions: We successfully developed SGOs from LSGBs of SjD patients, allowing long-term culture and faithfully recapitulating the disease phenotype. This model holds promise as a valuable tool for drug screening.
Copyright © 2025 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Competing interests GN received honoraria from Biogen, Pfizer, Novartis, Lilly, and Amgen. XM received honoraria from Bristol Myers Squibb, GSK, Novartis, Otsuka, and Pfizer. The remaining authors declare that they have no known competing financial interests.
Similar articles
-
Elucidating Regulatory Mechanisms of Genes Involved in Pathobiology of Sjögren's Disease: Immunostimulation Using a Cell Culture Model.Int J Mol Sci. 2025 Jun 19;26(12):5881. doi: 10.3390/ijms26125881. Int J Mol Sci. 2025. PMID: 40565345 Free PMC article.
-
Clinical, histopathological, and immunohistochemical characteristics of patients with sicca syndrome with a focus score ≥ 1 in the minor salivary gland biopsy.Biomedica. 2025 Mar 28;45(1):80-93. doi: 10.7705/biomedica.7315. Biomedica. 2025. PMID: 40257948 Free PMC article. English, Spanish.
-
SHP2 Allosteric Inhibitor SHP099 Alleviates Inflammation and Restores Salivary Gland Function in Sjögren's Disease-like Animals via Regulation of the IL-17RA Signaling Pathway.Int Immunopharmacol. 2025 Aug 28;161:114986. doi: 10.1016/j.intimp.2025.114986. Epub 2025 Jun 3. Int Immunopharmacol. 2025. PMID: 40466613
-
The diagnostic power of salivary electrolytes for Sjögren's disease: a systematic literature review and meta-analysis.Clin Exp Rheumatol. 2023 Dec;41(12):2511-2524. doi: 10.55563/clinexprheumatol/648k4u. Epub 2023 Nov 29. Clin Exp Rheumatol. 2023. PMID: 38079344
-
Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review.Autoimmun Rev. 2013 Jan;12(3):416-20. doi: 10.1016/j.autrev.2012.08.001. Epub 2012 Aug 7. Autoimmun Rev. 2013. PMID: 22889617
MeSH terms
LinkOut - more resources
Full Text Sources
Medical